The clinical characteristics of NSCLC patients with BRAF mutations are not well defined, perhaps due to the low frequency observed in NSCLC patients, however they are strongly associated with adenocarcinoma histology [20]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.